Time & Date: 2 September, 16:30 – 17:30 CEST
Chairperson(s): R. Hussain UK & T. Peto UK
Speakers & Presentations:
T. Peto UK
16:30 Welcome
T. Peto UK
16:32 UK Biobank retinal imaging grading: methodology, baseline characteristics and findings for common ocular diseases
Y. Asad INDIA
16:38 Covid 19 and retina: Scourge of Covid and its retinal complications
G. Midena ITALY
16:44 Retinal Radiation-Induced Neuroinflammation in the Pathophysiology of Radiation Macular Edema: an Omic and Imaging Combined Diagnostic Approach
M. J. Sirks THE NETHERLANDS
16:50 Wordwide use of verteporfin (Visudyne®) for photodynamic therapy for ophthalmic diseases and clinical impact of recent shortage
S. Sen INDIA
16:56 Profiling of idiopathic macular hole vitreous proteome using label-free comparative quantitative mass spectrometry identifies role of extracellular matrix remodelling, epithelial-mesenchymal transformation and unfolded protein-response pathways
E. Kilic THE NETHERLANDS
17:02 Trends in epidemiology of Ocular Melanoma
G.E. Bravetti SWITERLAND
17:08 Diurnal Variation of Serous Retinal Detachment during BRAF and MEK Inhibitor Treatment
M. J. Jager THE NETHERLANDS
17:14 Clinical Evaluation of AU-011, a First-in-Class Targeted Therapy for Choroidal Melanoma, with Intravitreal or Suprachoroidal Route of Administration
R. Hussain UK
17:20 OCT changes following trans-retinal choroidal biopsy for uveal melanoma prognostication
All Faculty
17:26 Discussion
